SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-08-007030
Filing Date
2008-06-18
Accepted
2008-06-18 16:18:54
Documents
1
Period of Report
2008-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y61307e8vk.htm 8-K 8974
  Complete submission text file 0000950123-08-007030.txt   10526
Mailing Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022 212-716-1810
Innovive Pharmaceuticals, Inc. (Filer) CIK: 0001337223 (see all company filings)

IRS No.: 743123261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51534 | Film No.: 08905853
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1